VOYT yields 20000000.00% · JNJ yields 2.13%● Live data
📍 VOYT pulled ahead of the other in Year 1
Combined, VOYT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VOYT + JNJ for your $10,000?
Voyant International Corp., through its subsidiaries, designs and delivers software technology to accelerate and manage large data transfers over IP networks. Its primary product families include RocketStream data transfer technology, which provides file transfer acceleration, automation, and security functions for market verticals, such as oil and gas, mining, entertainment, legal, financial services, military, and medical; and RocketConnect, a software-based product designed to accelerate data traversing between a telephone switching center and consumer's premises or mobile devices. The company also intends to provide an array of network-based products and services while airborne, including Internet access, email, PDA access, and advertising and multimedia content. In addition, it is developing remotely configurable, broadband radios that operate in the white space portion of the spectrum between VHF and UHF television stations. The company was formerly known as Zeros & Ones, Inc. and changed its name to Voyant International Corp. in April 2007. Voyant International Corp. is based in Hollywood, California.
Full VOYT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.